Jon B. Rousseau - 04 Mar 2026 Form 4 Insider Report for BrightSpring Health Services, Inc. (BTSG)

Role
Title: Chairman, President and Chief Executive Officer, Director
Signature
/s/ Jennifer Phipps, as Attorney-in-Fact
Issuer symbol
BTSG
Transactions as of
04 Mar 2026
Net transactions value
-$9,053,000
Form type
4
Filing time
06 Mar 2026, 19:45:35 UTC
Previous filing
27 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ROUSSEAU JON B Title: Chairman, President and Chief Executive Officer, Director C/O BRIGHTSPRING HEALTH SERVICES, INC., 805 N. WHITTINGTON PARKWAY, LOUISVILLE /s/ Jennifer Phipps, as Attorney-in-Fact 06 Mar 2026 0001579775

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTSG Common Stock Options Exercise +220,000 +21% $6.37* 1,243,880 04 Mar 2026 Direct
transaction BTSG Common Stock Sale $9,053,000 -220,000 -18% $41.15 1,023,880 04 Mar 2026 Direct F1
transaction BTSG Common Stock Award +186,845 +18% $0.000000* 1,210,725 05 Mar 2026 Direct F2
holding BTSG Common Stock 369,763 04 Mar 2026 By Rousseau Family Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BTSG Stock Options (Right to Buy) Award +955,823 +171% $0.000000* 1,516,064 04 Mar 2026 Common Stock 955,823 $6.37 Direct F4
transaction BTSG Stock Options (Right to Buy) Options Exercise -220,000 -15% $0.000000* 1,296,064 04 Mar 2026 Common Stock 220,000 $6.37 Direct F5
transaction BTSG Stock Options (Right to Buy) Award +458,008 $0.000000* 458,008 05 Mar 2026 Common Stock 458,008 $41.77 Direct F6
holding BTSG Stock Options (Right to Buy) 534,676 04 Mar 2026 Common Stock 534,676 $6.37 By The Margaret Rousseau Children Trust F3, F5
holding BTSG Stock Options (Right to Buy) 377,602 04 Mar 2026 Common Stock 377,602 $6.37 By Rousseau Family Trust F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on March 4, 2026, at a price of $41.15, before deducting underwriting discounts and commissions.
F2 On March 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which vest in twelve equal quarterly installments commencing on April 25, 2026. Each RSU represents a contingent right to receive one share of common stock upon settlement.
F3 The Reporting Person states that this filing shall not be an admission that the Reporting Person is the beneficial owner of any of the securities reported herein as indirectly owned, and the Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest therein.
F4 No new stock options have been awarded. The transaction reported herein reflects vesting of performance-based stock options ("Performance Options") previously awarded to the Reporting Person on October 16, 2019, vesting subject to performance conditions that were subsequently satisfied on March 3, 2026. The Performance Options are fully vested.
F5 These options are fully vested.
F6 Options vest in twelve equal quarterly installments commencing on April 25, 2026.

Remarks:

Title: Chairman, President and Chief Executive Officer